Science Explorer Interactive view Map
Company · Cambridge · United States

BioNTech (United States)

biontech.deROR OpenAlex
Research works
81
▲ 395% vs 2013–17
Citations
2.7k
32.7 per fractional work
Top-10% rate
23.9%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: BioNTech (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.23× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.65× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 10.95× its world share, 3 worksImmunology and Micro…Neuroscience: 0.20× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.17× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.77× its world share, 0 worksChemical EngineeringChemistry: 0.77× its world share, 0 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEngineering: 0.31× its world share, 2 worksEngineeringEnvironmental Science: 0.83× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.37× its world share, 0 worksMaterials ScienceMathematics: 3.26× its world share, 1 worksMathematicsHealth Professions: 0.03× its world share, 0 worksHealth ProfessionsMedicine: 2.25× its world share, 14 worksMedicineBusiness, Management and Accounting: 0.17× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.54× its world share, 0 worksEconomics, Econometr…Psychology: 0.03× its world share, 0 worksPsychologySocial Sciences: 0.11× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.9×. Every wedge is a field page.

Which keywords describe research at BioNTech (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Cancer Immunotherapy, Tumor Regression, Immunity, Gene Therapy, Lymphoma, CAR T Cells and Chimeric Antigen Receptor.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Immunotherapy4▲ 17×8 topics
  2. Cancer Immunotherapy4▲ 75×2 topics
  3. Tumor Regression3▲ 90×2 topics
  4. Immunity3▲ 22×3 topics
  5. Gene Therapy3▲ 43×5 topics
  6. Lymphoma2▲ 48×2 topics
  7. CAR T Cells2▲ 99×1 topic
  8. Chimeric Antigen Receptor2▲ 99×1 topic
  9. Chemotherapy2▲ 10.0×10 topics
  10. Antigen Presentation2▲ 76×2 topics
  11. Epidemiology2▲ 1.55×21 topics
  12. SARS-CoV-22▲ 18×4 topics
  13. Pandemic2▲ 5.5×5 topics
  14. Tumor Microenvironment2▲ 13×5 topics
  15. ACE2 Receptor2▲ 22×2 topics
  16. Vaccine2▲ 14×6 topics
  17. Diagnosis2▲ 5.4×7 topics
  18. Treatment2▲ 4.1×8 topics
  19. Viral Transmission2▲ 32×2 topics
  20. Coronavirus1▲ 22×2 topics
  21. Innate Immunity1▲ 14×3 topics
  22. Monoclonal Antibodies1▲ 51×2 topics
  23. antibody1▲ 42×1 topic
  24. spike protein1▲ 42×1 topic
  25. Dendritic Cells1▲ 47×1 topic
  26. Tumor Antigen1▲ 69×1 topic
  27. Tumor Targeting1▲ 21×3 topics
  28. Biomarkers1▲ 5.4×6 topics
  29. Inflammation1▲ 1.74×9 topics
  30. Risk Factors1▲ 3.3×3 topics
  31. Targeted Therapy1▲ 16×4 topics
  32. Assembly Planning1▲ 42×1 topic
  33. Cancer Therapy1▲ 5.9×5 topics
  34. Design for Manufacture1▲ 42×1 topic
  35. Germ Cell Tumors1▲ 206×1 topic
  36. Immune Response1▲ 5.7×9 topics
  37. Testicular Cancer1▲ 206×1 topic

Which research topics does BioNTech (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses and Manufacturing Process and Optimization.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksSARS-CoV-2 and COVID-19 Research: 1 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksManufacturing Process an…1Manufacturing Process and Optimization: 1 fractional worksTesticular diseases and treatments: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksVirus-based gene therapy…1Virus-based gene therapy research: 1 fractional worksCancer Research and Treatments: 1 fractional worksCRISPR and Genetic Engineering: 1 fractional worksvaccines and immunoinfor…1vaccines and immunoinformatics approaches: 1 fractional works
OncologyInfectious DiseasesImmunologyIndustrial and Manufacturing Engineering4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  3. 3 Immunotherapy and Immune Responses Immunology 1 works
  4. 4 Manufacturing Process and Optimization Industrial and Manufacturing Engineering 1 works
  5. 5 Testicular diseases and treatments Surgery 1 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
  7. 7 Virus-based gene therapy research Genetics 1 works
  8. 8 Cancer Research and Treatments Biotechnology 1 works
  9. 9 CRISPR and Genetic Engineering Molecular Biology 1 works
  10. 10 vaccines and immunoinformatics approaches Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.9%not open48.1%

World: 28% of research is openly available.

with international co-authors49.7%domestic only50.3%

World: 19% is written across borders.

How has BioNTech (United States)'s research output changed?

Output in 2018–2022 was 395% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.